Lipitension – myth or reality? Opinion of a practicing cardiologist (letter to the editor) by V. V. Kashtalap

Get full text

Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation) by V. V. Kashtalap

Get full text

Endothelial protective effect of pitavastatin by A. S. Berns, V. V. Kashtalap

Get full text

Single-pill combination of indapamide and perindopril: potential of practical application by A. M. Kochergina, V. V. Kashtalap

Get full text

LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS by O. L. Barbarash, V. V. Kashtalap

Get full text

Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus by O. L. Barbarash, V. V. Kashtalap

Get full text

A patient with сoronary artery disease and multifocal atherosclerosis. How to optimize the prognosis? by O. L. Barbarash, V. V. Kashtalap

Get full text

Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban by O. L. Barbarash, V. V. Kashtalap

Get full text

A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel by V. V. Kashtalap, O. L. Barbarash

Get full text

ACTUAL PROBLEMS OF ANTITOMBOTIC THERAPY IN ACUTE CORONARY SYNDROME (FOLLOWING THE MATERIAL PRESENTED AT THE EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2017) by V. V. Kashtalap, O. L. Barbarash

Get full text

Clopidogrel as a part of double disaggregant therapy in ACS: a reasonable choice in complex clinical situations by V. V. Kashtalap, O. L. Barbarash

Get full text

TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS by O. L. Barbarash, V. V. Kashtalap

Get full text

Risk factors for non-adherence to oral anticoagulant therapy and the potential of their modification in patients with atrial fibrillation: a narrative literature review by I. M. Felikov, V. V. Kashtalap

Get full text

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice by O. L. Barbarash, V. V. Kashtalap

Get full text

A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS by O. L. Barbarash, V. V. Kashtalap

Get full text

"NEW" PATHOLOGICAL CONTINUUM: A HYPOGONADISM, AN OSTEOPOROSIS AND THE CALCINATING ATHEROSCLEROSIS. GENERAL FACTORS OF FORMATION AND PROGRESSION by V. V. Kashtalap, O. N. Hryachkova, O. L. Barbarash

Get full text

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? by O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova

Get full text

Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? by D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash

Get full text

Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Keme... by D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash

Get full text

Galectin-3 – prospective biomarker of risk stratification in patients with ST-segment elevation myocardial infarction by N. V. Fedorova, V. V. Kashtalap, O. N. Khryachkova, O. L. Barbarash

Get full text